| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Common Stock | Sale | $332,661 | -6,600 | -37% | $50.40 | 11,396 | 21 Aug 2023 | Direct | F1, F2, F3 |
| holding | BSX | Common Stock | 2,544 | 21 Aug 2023 | By 401(k) | F4 |
| Id | Content |
|---|---|
| F1 | The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2023, intended to comply with the prior version of Rule 10b5-1(c). |
| F2 | Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $50.26 to $50.54, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Includes shares acquired on June 30, 2023 under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available. |
| F4 | Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. |